Critical assessment of randomized controlled trials published in biomedical Chilean journals;Análisis crítico de ensayos clínicos randomizados publicados en revistas biomédicas chilenas

Revista Medica de Chile

Volumn 133, Issue 4, 2005, Pages 439-446

  Manríquez M, Juan ^a   Valdivia C, Gonzalo ^b   Rada G, Gabriel ^a   Letelier S, Luz María ^a,b,c  

^a Unidad de Medicina Basada en Evidencia (UMBE UC)   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c HOSPITAL DR SÓTERO DEL RÍO   (Chile)

Author keywords

Methods; Periodicals; Publications; Randomized controlled trials

Indexed keywords

ARTICLE; BIBLIOMETRICS; CHILE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EVALUATION; HUMAN; METHODOLOGY; PUBLICATION; RANDOMIZED CONTROLLED TRIAL; STANDARD; STATISTICS;

BIBLIOMETRICS; CHILE; HUMANS; PERIODICALS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN;

EID: 31144469384     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. POCOCK SJ, HUGHES MD, LEE RJ. Statistical problems in the reporting of clinical trials. A survey of three medical journals. N Engl J Med 1987; 317: 426-32.
2. KUNZ R, VIST G, OXMAN AD. Randomization to protect against selection bias in healthcare trials (Cochrane Methodology Review). In: The Cochrane Library, Issue 2, 2004. Chichester, UK: John Wiley & Sons, Ltd.
3. MOHER D. Consort: an evolving tool to help improve the quality of reports of randomized controlled trials. Consolidated Standards of Reporting Trials. JAMA 1998; 279: 1489-91.
4. MOHER D, DULBERG CS, WELLS GA. Statistical power, sample size, and their reporting in randomized controlled trials. JAMA 1994; 272: 122-4.
5. FREIMAN JA, CHALMERS TC, SMITH H JR, KUEBLER RR. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. N Engl J Med 1978; 299: 690-4.
6. ADETUGBO K, WILLIAMS H. How well are randomized controlled trials reported in the dermatology literature? Arch Dermatol 2000; 136: 381-5.
7. GLAVAN B, SHEWAKRAMANI S, HOLLANDER J. Incomplete data reporting in studies of emergency department patients with potential acute coronary syndromes using troponins. Acad Emerg Med 2003; 10: 943-8.
8. ALTMAN DG, DORE CJ. Randomization and baseline comparisons in clinical trials. Lancet 1990; 335: 149-53.
9. THORNLEY B, ADAMS C. Content and quality of 2000 controlled trials in schizophrenia over 50 years. BMJ 1998; 317: 1181-4.
10. SCHULZ KF, CHALMERS I, HAYES RJ, ALTMAN DG. Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408-12.
11. Unidad de Evaluación de Tecnologías de Salud. Ministerio de Salud de Chile. 2004. Disponible en: http://www.minsal.cl/ [Consultado el 01 de junio de 2004].
12. JADAD AR, MOORE RA, CARROLL D, JENKINSON C, REYNOLDS DJ, GAVAGHAN DJ ET AL. Assessing the quality of reports on randomized clinical trials: Is blinding necessary? Controlled Clin Trials 1996; 17: 1-12.
13. HALL JC, MILLS B, NGUYEN H, HALL JL. Methodologic standards in surgical trials. Surgery 1996; 119: 466-72.
14. KJAERGARD L, VILLUMSEN J, GLUUD C. Quality of randomized clinical trials affects estimates of intervention efficacy. Abstracts for Workshops and Scientific Sessions, 7th International Cochrane Colloquium, Rome, Italy, 1999.
15. JUNI P, ALTMAN DG, EGGER M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001; 323: 42-6.
16. SCHULZ KF, CHALMERS I, GRIMES DA, ALTMAN DG. Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. JAMA 1994; 272: 125-8.
17. SCHULZ KF. Randomized trials, human nature, and reporting guidelines. Lancet 1996; 348: 596-8.
18. AH-SEE KW, MOLONY NC. A qualitative assessment of randomized controlled trials in otolaryngology. J Laryngol Otol 1998; 112: 460-3.
19. BATH FJ, OWEN VE, BATH PM. Quality of full and final publications reporting acute stroke trials: a systematic review. Stroke 1998; 29: 2203-10.
20. ALTMAN DG, DORE CJ. Randomization and baseline comparisons in clinical trials. Lancet 1990; 335: 149-53.
21. CARROLL D, TRAMER M, MCQUAY H, NYE B, MOORE A. Randomization is important in studies with pain outcomes: systematic review of transcutaneous electrical nerve stimulation in acute postoperative pain. Br J Anaesth 1996; 77: 798-803.
22. GOTZSCHE PC. Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis. Control Clin Trials 1989; 10: 31-56.
23. DAY S, ALTMAN D. Statistics notes: blinding in clinical trials and other studies. BMJ 2000; 321: 504.
24. DEVEREAUX PJ, MANNS BJ, GHALI WA ET AL. Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. JAMA 2001; 285: 2000-3.
25. SCHULZ K, CHALMERS I, ALTMAN D. The landscape and lexicon of blinding in randomized trials. Ann Intern Med 2002; 136: 254-9.
26. BANG H, NI L, DAVIS C. Assessment of blinding in clinical trials. Control Clin Trials 2004; 25: 143-56.
27. SCHULZ K, GRIMES D. Blinding in randomized trials: hiding who got what. Lancet 2002; 359: 696-700.
28. ERNST E, WHITE AR. Acupuncture for back pain: A meta-analysis of randomized controlled trials. Arch Int Med 1998; 158: 2235-41.
29. ALTMAN DG, SCHULZ KF, MOHER D, EGGER M, DAVIDOFF F, ELBOURNE D ET AL. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001; 134: 663-94.
30. CHENG K, SMYTH RL, MOTLEY J, O'HEA U, ASHBY D. Randomized controlled trials in cystic fibrosis (1966-1997) categorized by time, design, and intervention. Pediatr Pulmonol 2000; 29: 1-7.
31. SCHULZ KF, GRIMES DA, ALTMAN DG, HAYES RJ. Blinding and exclusions after allocation in randomized controlled trials: survey of published parallel group trials in obstetrics and gynaecology. BMJ 1996; 312: 742-4.
32. SCHULZ KF. Randomized controlled trials. Clin Obstet Gynecol 1998; 41: 245-56.
33. SACKETT DL, GENT M. Controversy in counting and attributing events in clinical trials. N Engl J Med 1979; 301: 1410-2.
34. EGGER M, JUNI P, BARTLETT C. Value of flow diagrams in reports of randomized controlled trials. The CONSORT Group. JAMA 2001; 285: 1996-9.
35. FIELDS WS, MASLENIKOV V, MEYER JS, HASS WK, REMINGTON RD, MACDONALD M. Joint study of extracranial arterial occlusion. V. Progress report of prognosis following surgery or nonsurgical treatment for transient cerebral ischemic attacks and cervical carotid artery lesions. JAMA 1970; 211: 1993-2003.
36. HOLLIS S, CAMPBELL F. What is meant by intention to treat analysis? Survey of published randomized controlled trials. BMJ 1999; 319: 670-4.
37. MOHER D, PHAM B, JONES A, COOK DJ, JADAD AR, MOHER M ET AL. Does quality of reports of randomized trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998; 352: 609-13.